Home > Publications database > The EVIglance randomized clinical trial: a new standard for answering a clinical question. > print

001     274146
005     20240229154927.0
024 7 _ |a 10.1093/bjs/znad049
|2 doi
024 7 _ |a pmid:36869829
|2 pmid
024 7 _ |a 0263-1202
|2 ISSN
024 7 _ |a 0007-1323
|2 ISSN
024 7 _ |a 1365-2168
|2 ISSN
024 7 _ |a altmetric:143214645
|2 altmetric
037 _ _ |a DKFZ-2023-00456
041 _ _ |a English
082 _ _ |a 610
100 1 _ |a Probst, Pascal
|b 0
245 _ _ |a The EVIglance randomized clinical trial: a new standard for answering a clinical question.
260 _ _ |a Oxford
|c 2023
|b Oxford University Press
336 7 _ |a article
|2 DRIVER
336 7 _ |a Output Types/Journal article
|2 DataCite
336 7 _ |a Journal Article
|b journal
|m journal
|0 PUB:(DE-HGF)16
|s 1681281155_18957
|2 PUB:(DE-HGF)
|x Letter
336 7 _ |a ARTICLE
|2 BibTeX
336 7 _ |a JOURNAL_ARTICLE
|2 ORCID
336 7 _ |a Journal Article
|0 0
|2 EndNote
536 _ _ |a 314 - Immunologie und Krebs (POF4-314)
|0 G:(DE-HGF)POF4-314
|c POF4-314
|f POF IV
|x 0
588 _ _ |a Dataset connected to CrossRef, PubMed, , Journals: inrepo02.dkfz.de
700 1 _ |a Merz, Daniela C
|b 1
700 1 _ |a Joos, Maximilian C
|0 0000-0003-2260-3964
|b 2
700 1 _ |a Ahmed, Azaz
|0 P:(DE-He78)bac8c2c56238485ecf0475ff14438430
|b 3
|u dkfz
700 1 _ |a Feisst, Manuel
|b 4
700 1 _ |a Klotz, Rosa
|0 0000-0003-4123-261X
|b 5
773 _ _ |a 10.1093/bjs/znad049
|g p. znad049
|0 PERI:(DE-600)2006309-X
|n 4
|p 515-517
|t The British journal of surgery
|v 110
|y 2023
|x 0263-1202
909 C O |p VDB
|o oai:inrepo02.dkfz.de:274146
910 1 _ |a Deutsches Krebsforschungszentrum
|0 I:(DE-588b)2036810-0
|k DKFZ
|b 3
|6 P:(DE-He78)bac8c2c56238485ecf0475ff14438430
913 1 _ |a DE-HGF
|b Gesundheit
|l Krebsforschung
|1 G:(DE-HGF)POF4-310
|0 G:(DE-HGF)POF4-314
|3 G:(DE-HGF)POF4
|2 G:(DE-HGF)POF4-300
|4 G:(DE-HGF)POF
|v Immunologie und Krebs
|x 0
914 1 _ |y 2023
915 _ _ |a DEAL Wiley
|0 StatID:(DE-HGF)3001
|2 StatID
|d 2022-11-18
|w ger
915 _ _ |a WoS
|0 StatID:(DE-HGF)0113
|2 StatID
|b Science Citation Index Expanded
|d 2022-11-18
915 _ _ |a DBCoverage
|0 StatID:(DE-HGF)0160
|2 StatID
|b Essential Science Indicators
|d 2022-11-18
915 _ _ |a Nationallizenz
|0 StatID:(DE-HGF)0420
|2 StatID
|d 2023-08-25
|w ger
915 _ _ |a DBCoverage
|0 StatID:(DE-HGF)0200
|2 StatID
|b SCOPUS
|d 2023-08-25
915 _ _ |a DBCoverage
|0 StatID:(DE-HGF)0300
|2 StatID
|b Medline
|d 2023-08-25
915 _ _ |a DBCoverage
|0 StatID:(DE-HGF)0199
|2 StatID
|b Clarivate Analytics Master Journal List
|d 2023-08-25
915 _ _ |a DBCoverage
|0 StatID:(DE-HGF)0150
|2 StatID
|b Web of Science Core Collection
|d 2023-08-25
915 _ _ |a DBCoverage
|0 StatID:(DE-HGF)1030
|2 StatID
|b Current Contents - Life Sciences
|d 2023-08-25
915 _ _ |a DBCoverage
|0 StatID:(DE-HGF)1110
|2 StatID
|b Current Contents - Clinical Medicine
|d 2023-08-25
915 _ _ |a JCR
|0 StatID:(DE-HGF)0100
|2 StatID
|b BRIT J SURG : 2022
|d 2023-08-25
915 _ _ |a DBCoverage
|0 StatID:(DE-HGF)0600
|2 StatID
|b Ebsco Academic Search
|d 2023-08-25
915 _ _ |a Peer Review
|0 StatID:(DE-HGF)0030
|2 StatID
|b ASC
|d 2023-08-25
915 _ _ |a IF >= 5
|0 StatID:(DE-HGF)9905
|2 StatID
|b BRIT J SURG : 2022
|d 2023-08-25
920 1 _ |0 I:(DE-He78)D240-20160331
|k D240
|l Translationale Immuntherapie
|x 0
980 _ _ |a journal
980 _ _ |a VDB
980 _ _ |a I:(DE-He78)D240-20160331
980 _ _ |a UNRESTRICTED

LibraryCollectionCLSMajorCLSMinorLanguageAuthor
Marc 21